Northside Capital Management LLC increased its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 1.0% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 5,352 shares of the healthcare conglomerate’s stock after purchasing an additional 54 shares during the period. UnitedHealth Group accounts for approximately 0.6% of Northside Capital Management LLC’s investment portfolio, making the stock its 18th biggest position. Northside Capital Management LLC’s holdings in UnitedHealth Group were worth $1,333,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in UNH. Capital International Investors raised its position in shares of UnitedHealth Group by 223.0% during the 3rd quarter. Capital International Investors now owns 16,319,843 shares of the healthcare conglomerate’s stock worth $4,341,731,000 after purchasing an additional 11,267,910 shares during the last quarter. FMR LLC grew its stake in UnitedHealth Group by 5.1% during the 2nd quarter. FMR LLC now owns 61,622,355 shares of the healthcare conglomerate’s stock valued at $15,118,428,000 after acquiring an additional 2,981,233 shares in the last quarter. Rehmann Capital Advisory Group grew its stake in UnitedHealth Group by 26,088.2% during the 3rd quarter. Rehmann Capital Advisory Group now owns 1,723,185 shares of the healthcare conglomerate’s stock valued at $6,477,000 after acquiring an additional 1,716,605 shares in the last quarter. Vontobel Asset Management Inc. purchased a new stake in UnitedHealth Group during the 2nd quarter valued at about $404,980,000. Finally, Vanguard Group Inc grew its stake in UnitedHealth Group by 1.6% during the 3rd quarter. Vanguard Group Inc now owns 69,342,549 shares of the healthcare conglomerate’s stock valued at $18,447,892,000 after acquiring an additional 1,073,505 shares in the last quarter. Hedge funds and other institutional investors own 85.28% of the company’s stock.
Shares of UnitedHealth Group stock traded up $1.28 during mid-day trading on Monday, hitting $248.95. The stock had a trading volume of 2,812,085 shares, compared to its average volume of 4,061,377. UnitedHealth Group Inc has a 12-month low of $208.48 and a 12-month high of $287.94. The company has a debt-to-equity ratio of 0.61, a current ratio of 0.69 and a quick ratio of 0.69. The stock has a market cap of $234.39 billion, a price-to-earnings ratio of 24.72, a price-to-earnings-growth ratio of 1.23 and a beta of 0.88.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.30 by $0.11. The firm had revenue of $56.56 billion during the quarter, compared to analysts’ expectations of $56.34 billion. UnitedHealth Group had a net margin of 5.71% and a return on equity of 23.62%. The firm’s quarterly revenue was up 12.4% on a year-over-year basis. During the same quarter last year, the company posted $2.66 EPS. Equities analysts expect that UnitedHealth Group Inc will post 12.81 earnings per share for the current fiscal year.
Several brokerages recently issued reports on UNH. Stephens began coverage on shares of UnitedHealth Group in a research note on Monday. They set an “overweight” rating and a $287.00 price objective for the company. Cleveland Research reaffirmed a “buy” rating on shares of UnitedHealth Group in a research note on Friday. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $279.00 price objective for the company in a research note on Saturday, January 5th. Argus upped their price objective on shares of UnitedHealth Group from $285.00 to $295.00 and gave the company a “buy” rating in a research note on Monday, December 17th. Finally, Raymond James set a $310.00 price objective on shares of UnitedHealth Group and gave the company a “buy” rating in a research note on Wednesday, November 28th. One equities research analyst has rated the stock with a hold rating and twenty-three have issued a buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $293.86.
In related news, Director Richard T. Burke sold 6,090 shares of the stock in a transaction that occurred on Wednesday, November 28th. The shares were sold at an average price of $281.72, for a total transaction of $1,715,674.80. Following the completion of the transaction, the director now owns 1,711,584 shares of the company’s stock, valued at approximately $482,187,444.48. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Kenneth Irwin Shine sold 163 shares of the stock in a transaction that occurred on Friday, November 9th. The stock was sold at an average price of $274.83, for a total transaction of $44,797.29. The disclosure for this sale can be found here. Company insiders own 0.87% of the company’s stock.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: Cost of Debt
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.